ZVRA
NASDAQ · Pharmaceuticals
Zevra Therapeutics Inc
$10.26
+0.16 (+1.58%)
Open$10.12
Previous Close$10.10
Day High$10.42
Day Low$10.04
52W High$15.04
52W Low$8.01
Volume—
Avg Volume998.4K
Market Cap694.64M
P/E Ratio11.92
EPS$0.97
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-48.0% upside
Current
$10.26
$10.26
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 125.88M | 30.86M | 109.96M |
| Net Income | 98.41M | -124,101,933 | 24.47M |
| Profit Margin | 78.2% | -424.5% | 22.3% |
| EBITDA | -69,626,398 | -97,531,026 | 54.29M |
| Free Cash Flow | — | — | 22.49M |
| Rev Growth | +116.7% | -6.2% | -4.5% |
| Debt/Equity | 0.40 | 1.50 | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |